ACRS

3.4401.71%
KB

Kevin Balthaser

Chief Financial Officer

Mr. Kevin Balthaser is Chief Financial Officer of Aclaris Therapeutics, Inc. from January 01, 2023. He joined Aclaris in 2017 and has served in a number of roles of increasing responsibility, as Vice President, finance since January 2022. Prior to joining Aclaris, Mr. Balthaser held various positions of increasing responsibility within the accounting and finance department at Lannett Company, Inc., a publicly traded generic pharmaceutical company, where he was also a Member of the team responsible for executing capital market transactions and acquisitions. Mr. Balthaser began his career with the international accounting firm PricewaterhouseCoopers LLP. Mr. Balthaser received an M.B.A. from Villanova University and a B.S. in finance from Pennsylvania State University. He is also a Member of the American Institute of Certified Public Accountants.

Positions